Jpmorgan Chase & Co »

Aspire Biopharma Hldgs Inc Wt Exp 021430 shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Aspire Biopharma Hldgs Inc Wt Exp 021430 (ASBPW) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Aspire Biopharma Hldgs Inc Wt Exp 021430

Tip: Access up to 7 years of quarterly data

All positions including Aspire Biopharma Hldgs Inc Wt Exp 021430 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aspire Biopharma Hldgs Inc Wt Exp 021430 by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.0k 100k 0.03
2025-03-31 $6.8k 100k 0.07

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430

Adage Capital Partners GP
Saba Capital Management
Linden Advisors
Aristeia Capital
Highbridge Capital Management
Toronto-Dominion Bank
OZ Management
Verition Fund Management
Barclays
Clear Street
Millennium Management
Alberta Investment Management Corporation
Antara Capital
D. E. Shaw & Co
Wolverine Asset Management

View all funds holding Aspire Biopharma Hldgs Inc Wt Exp 021430